Dependent and paranoid personality patterns in myotonic dystrophy type 1

被引:14
|
作者
Peric, S. [1 ]
Sreckov, M. [2 ]
Basta, I. [1 ]
Lavrnic, D. [1 ]
Vujnic, M. [1 ]
Marjanovic, I. [1 ]
Stojanovic, V. Rakocevic [1 ]
机构
[1] Univ Belgrade, Sch Med, Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia
[2] Univ Belgrade, Sch Med, Clin Ctr Serbia, Psychiat Clin, Belgrade, Serbia
来源
ACTA NEUROLOGICA SCANDINAVICA | 2014年 / 129卷 / 04期
关键词
Millon Multiaxial Clinical Inventory; myotonic dystrophy type 1; quality of life; paranoid; personality pattern; dependent; MUSCULAR-DYSTROPHY; SCALE; DM-1;
D O I
10.1111/ane.12173
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives To analyze frequency and type of personality pattern in patients with myotonic dystrophy type 1 (DM1), to correlate these findings with clinical data, and to assess its possible influence on quality of life (QoL). Materials and Methods This cross-sectional study comprised 62 patients with DM1. Following measures were used: Muscular Impairment Rating Scale, Raven's Standard Progressive Matrices (RSPM), Millon Multiaxial Clinical Inventory I (MMCI), SF-36, and Individualized Neuromuscular Quality of Life (INQoL) questionnaires. Results The presence of at least one pathological personality trait with score above 85 on MMCI was found in 47 (75.8%) patients. After clinical interview, 36 (58.1%) subjects had significant personality impairment. The most common personality trait in our cohort of patients was dependent found in 51.6% of patients, followed by paranoid (38.7%). Higher score on dependent personality scale correlated with lower education (rho=-0.251, P=0.049). Dependent personality scores significantly differed between patients with physical and intellectual work (93.1 +/- 8.9 vs 66.9 +/- 31.7, P=0.011). Paranoid score was higher in patients with lower education (rho=-0.293, P=0.021), lower score on RSPM test (rho=-0.398, P=0.004) and larger number of CTG repeats (rho=0.254, P=0.046). Presence of dependent personality was not in association with QoL scores (P>0.05). On the other hand, patients with paranoid personality trait had worse QoL than those without it (P<0.05). Conclusion Almost 60% of our patients with DM1 had clinically significant personality impairment, with dependent and paranoid personality patterns being the most common. Paranoid personality may decrease QoL in these patients, which gives us new opportunities for symptomatic therapy in DM1.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 50 条
  • [41] Cardiac involvement in Myotonic Dystrophy Type 1
    Yueceyar, Nur
    Bicak, Nijer
    Kayikcioglu, Meral
    Ekmekci, Oezguel
    Karasoy, Hatice
    NEUROMUSCULAR DISORDERS, 2006, 16 : S122 - S122
  • [42] Echocardiography in patients with myotonic dystrophy type 1
    Peric, S. Z.
    Paunic, T.
    Dobricic, V.
    Novakovic, I.
    Basta, I.
    Lavrnic, D.
    Rakocevic-Stojanovic, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 205 - 205
  • [43] Teaching NeuroImages: Myotonic dystrophy type 1
    Zhang, Bingjun
    Yang, Yu
    Wu, Haotian
    Liao, Siyuan
    Lu, Zhengqi
    NEUROLOGY, 2018, 91 (13) : E1269 - E1270
  • [44] Multiorgan manifestations in myotonic dystrophy type 1
    Varga David
    Pal Endre
    ORVOSI HETILAP, 2019, 160 (37) : 1447 - 1454
  • [45] Pathogenesis of myotonic dystrophy type 1.
    Magana, Jonathan J.
    Leyva-Garcia, Norberto
    Cisneros, Bulmaro
    GACETA MEDICA DE MEXICO, 2009, 145 (04): : 331 - 337
  • [46] Erectile dysfunction in myotonic dystrophy type 1
    Clemenzi, A
    Bucci, E
    Di Pasquale, A
    Morino, S
    Ceschin, V
    Gragnani, R
    Antonini, G
    JOURNAL OF NEUROLOGY, 2004, 251 : 84 - 84
  • [47] Arrhythmia Management in Myotonic Dystrophy Type 1
    Groh, William J.
    Bhakta, Deepak
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (04): : 337 - 338
  • [48] Targeting Myotonic Dystrophy Type 1 with Metformin
    Garcia-Puga, Mikel
    Saenz-Antonanzas, Ander
    Matheu, Ander
    Lopez de Munain, Adolfo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [49] Muscle MRI in myotonic dystrophy type 1
    Garibaldi, M.
    Bucci, E.
    Cristiano, L.
    Morino, S.
    Fionda, L.
    Vanoli, F.
    Leonardi, L.
    Pennisi, E.
    Tartaglione, T.
    Petrucci, A.
    Antonini, G.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S112 - S112
  • [50] THERAPEUTICS DEVELOPMENT IN MYOTONIC DYSTROPHY TYPE 1
    Foff, Erin Pennock
    Mahadevan, Mani S.
    MUSCLE & NERVE, 2011, 44 (02) : 160 - 169